ORPEF
Price
$14.22
Change
+$0.37 (+2.67%)
Updated
Jul 22 closing price
Capitalization
2.45B
RAFLF
Price
$0.83
Change
+$0.02 (+2.47%)
Updated
Aug 5 closing price
Capitalization
1.5B
Interact to see
Advertisement

ORPEF vs RAFLF

Header iconORPEF vs RAFLF Comparison
Open Charts ORPEF vs RAFLFBanner chart's image
Orpea ACT
Price$14.22
Change+$0.37 (+2.67%)
Volume$400
Capitalization2.45B
Raffles Medical Group
Price$0.83
Change+$0.02 (+2.47%)
Volume$1K
Capitalization1.5B
ORPEF vs RAFLF Comparison Chart in %
Loading...
RAFLF
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
ORPEF vs. RAFLF commentary
Aug 11, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ORPEF is a Hold and RAFLF is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Aug 11, 2025
Stock price -- (ORPEF: $14.22 vs. RAFLF: $0.83)
Brand notoriety: ORPEF and RAFLF are both not notable
Both companies represent the Hospital/Nursing Management industry
Current volume relative to the 65-day Moving Average: ORPEF: 100% vs. RAFLF: 7%
Market capitalization -- ORPEF: $2.45B vs. RAFLF: $1.5B
ORPEF [@Hospital/Nursing Management] is valued at $2.45B. RAFLF’s [@Hospital/Nursing Management] market capitalization is $1.5B. The market cap for tickers in the [@Hospital/Nursing Management] industry ranges from $89.29B to $0. The average market capitalization across the [@Hospital/Nursing Management] industry is $3.86B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

ORPEF’s FA Score shows that 0 FA rating(s) are green whileRAFLF’s FA Score has 1 green FA rating(s).

  • ORPEF’s FA Score: 0 green, 5 red.
  • RAFLF’s FA Score: 1 green, 4 red.
According to our system of comparison, RAFLF is a better buy in the long-term than ORPEF.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

RAFLF’s TA Score shows that 1 TA indicator(s) are bullish.

  • RAFLF’s TA Score: 1 bullish, 2 bearish.

Price Growth

ORPEF (@Hospital/Nursing Management) experienced а 0.00% price change this week, while RAFLF (@Hospital/Nursing Management) price change was +2.54% for the same time period.

The average weekly price growth across all stocks in the @Hospital/Nursing Management industry was +5.15%. For the same industry, the average monthly price growth was -2.39%, and the average quarterly price growth was +9.50%.

Industries' Descriptions

@Hospital/Nursing Management (+5.15% weekly)

Hospital/Nursing Management companies own and operate health care facilities. Their operations include nursing homes, acute care facilities, retirement centers and outpatient surgery centers. HCA Healthcare Inc., Alcon Inc. and Universal Health Services, Inc. are some major companies in this industry. Technology has been at the forefront of development of advanced solutions, including quicker diagnoses of complex conditions. Investments in new diagnostics, healthcare IoT, and other healthcare technologies continue to gather momentum in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
ORPEF($2.45B) has a higher market cap than RAFLF($1.5B). RAFLF has higher P/E ratio than ORPEF: RAFLF (31.02) vs ORPEF (0.03). RAFLF YTD gains are higher at: 24.089 vs. ORPEF (0.000).
ORPEFRAFLFORPEF / RAFLF
Capitalization2.45B1.5B163%
EBITDAN/A137M-
Gain YTD0.00024.089-
P/E Ratio0.0331.020%
RevenueN/A764M-
Total CashN/A334M-
Total DebtN/A83.8M-
FUNDAMENTALS RATINGS
ORPEF vs RAFLF: Fundamental Ratings
ORPEF
RAFLF
OUTLOOK RATING
1..100
5050
VALUATION
overvalued / fair valued / undervalued
1..100
92
Overvalued
18
Undervalued
PROFIT vs RISK RATING
1..100
10070
SMR RATING
1..100
9079
PRICE GROWTH RATING
1..100
7040
P/E GROWTH RATING
1..100
9845
SEASONALITY SCORE
1..100
n/a50

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

RAFLF's Valuation (18) in the null industry is significantly better than the same rating for ORPEF (92). This means that RAFLF’s stock grew significantly faster than ORPEF’s over the last 12 months.

RAFLF's Profit vs Risk Rating (70) in the null industry is in the same range as ORPEF (100). This means that RAFLF’s stock grew similarly to ORPEF’s over the last 12 months.

RAFLF's SMR Rating (79) in the null industry is in the same range as ORPEF (90). This means that RAFLF’s stock grew similarly to ORPEF’s over the last 12 months.

RAFLF's Price Growth Rating (40) in the null industry is in the same range as ORPEF (70). This means that RAFLF’s stock grew similarly to ORPEF’s over the last 12 months.

RAFLF's P/E Growth Rating (45) in the null industry is somewhat better than the same rating for ORPEF (98). This means that RAFLF’s stock grew somewhat faster than ORPEF’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
ORPEFRAFLF
RSI
ODDS (%)
N/A
N/A
Stochastic
ODDS (%)
N/A
Bearish Trend 4 days ago
38%
Momentum
ODDS (%)
N/A
N/A
MACD
ODDS (%)
N/A
Bearish Trend 4 days ago
19%
TrendWeek
ODDS (%)
Bullish Trend 4 days ago
24%
Bullish Trend 4 days ago
22%
TrendMonth
ODDS (%)
Bullish Trend 4 days ago
18%
Bullish Trend 4 days ago
22%
Advances
ODDS (%)
N/A
N/A
Declines
ODDS (%)
N/A
N/A
BollingerBands
ODDS (%)
N/A
N/A
Aroon
ODDS (%)
N/A
Bullish Trend 4 days ago
27%
View a ticker or compare two or three
Interact to see
Advertisement
RAFLF
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
FTXSX46.46-0.04
-0.09%
FullerThaler Behavioral Sm-Cp GrInstl
IBCGX14.44-0.08
-0.55%
VY® Baron Growth S2
TRQZX101.57-0.86
-0.84%
T. Rowe Price Mid-Cap Growth Z
GREAX10.96-0.12
-1.08%
Goldman Sachs Real Estate Securities A
HFDRX18.47-0.21
-1.12%
Hartford Schroders US MidCap Opps R3

ORPEF and

Correlation & Price change

A.I.dvisor indicates that over the last year, ORPEF has been loosely correlated with DCGO. These tickers have moved in lockstep 37% of the time. This A.I.-generated data suggests there is some statistical probability that if ORPEF jumps, then DCGO could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ORPEF
1D Price
Change %
ORPEF100%
N/A
DCGO - ORPEF
37%
Loosely correlated
+12.95%
MFCSF - ORPEF
4%
Poorly correlated
-0.67%
KJFI - ORPEF
0%
Poorly correlated
N/A
JRSS - ORPEF
-0%
Poorly correlated
N/A
NWKHY - ORPEF
-0%
Poorly correlated
N/A
More

RAFLF and

Correlation & Price change

A.I.dvisor tells us that RAFLF and HLYK have been poorly correlated (+17% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that RAFLF and HLYK's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To RAFLF
1D Price
Change %
RAFLF100%
N/A
HLYK - RAFLF
17%
Poorly correlated
-6.02%
LTGHY - RAFLF
0%
Poorly correlated
+0.31%
KJFI - RAFLF
0%
Poorly correlated
N/A
ORPEF - RAFLF
-0%
Poorly correlated
N/A
NWKHY - RAFLF
-0%
Poorly correlated
N/A
More